We are a full service construction company with development capabilities. We are defined by the communities that we serve. We believe that each of our projects, no matter the size or type, plays an important role in strengthening and developing a healthy
Read More
Monument Biosciences is a preclinical stage biopharmaceutical company bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD). Our discovery programs are anchored in human patient genetics, rece
Read More
Morgan County, Indiana gives your business a central Indiana location that’s well-connected, affordable, and in the middle of a 50-mile labor shed of more than 1.2 million workers. We’re just southwest of Indianapolis and within a single-day’s truck drive
Read More
Moxie Medical Group is an early phase start up company developing revolutionary orthopedic surgical tools.
Read More
Based in Indianapolis, Indiana, Helix BioStructures, LLC (HBS) is a contract research organization (CRO) providing Drug Discovery services to the Biopharmaceutical Industry.
A typical Drug Development pipeline consists of several phases. HBS occupies the
Helmer Scientific provides medical-grade, temperature controlled storage and processing solutions and services for pharmacy, blood bank, laboratory and research.
Read More
Isotopia USA, Inc. is a developer and manufacturer or radioactive isotopes utilized as drug substances by radiopharmaceutical companies to produce targeted cancer therapies.
Read More
Founded in February 2000, Key Corporate Services has established itself as a premier, niche recruiting firm focused in Pharmaceutical and Biotech, CMO, CDMO, and CRO. I help industry leading companies by identifying and guiding high-performing candidates
Read More
Kovina Therapeutics is a preclinical drug discovery company focused on stopping human papillomavirus (HPV) premalignant infections before cancer develops and treating HPV cancers after detection. Kovina’s novel small molecule antiviral compounds bind to a
Read More
Grannus is an early-stage oncology drug development company, with a unique approach to a well-validated target, the chaperone protein Hsp90, that has demonstrated efficacy in clinical studies but known limitations that have prevented previous drugs from b
Read More